New York, New York-- (Newsfile Corp. - March 5, 2025) - Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against BioAge Labs, Inc. (NASDAQ: BIOA) and ...
BioAge Labs, Inc. (BIOA – Research Report) received a Hold rating and price target from William Blair analyst Andy Hsieh today. The company’s ...
SAN FRANCISCO, March 03, 2025 (GLOBE NEWSWIRE) -- BioAge Labs, Inc. (NASDAQ: BIOA) is abandoning development of its lead obesity candidate, azelaprag, just weeks after halting a Phase 2 trial.
Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds BioAge Labs, Inc. (“BioAge” or the “Company”) (NASDAQ: BIOA) investors of an upcoming deadline involving a ...
Fintel reports that on February 28, 2025, William Blair initiated coverage of BioAge Labs (NasdaqGS:BIOA) with a Market ...
NEW YORK--(BUSINESS WIRE)--The law firm of Kirby McInerney LLP reminds investors of the March 10, 2025, deadline to seek the role of lead plaintiff in a federal securities class action filed on behalf ...
LOS ANGELES, CA / ACCESS Newswire / February 8, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces the firm has filed a class action lawsuit against BioAge Labs ...
NEW YORK CITY, NY / ACCESS Newswire / February 19, 2025 / Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against BioAge Labs, Inc. (NASDAQ ...
New York, New York--(Newsfile Corp. - February 19, 2025) - Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against BioAge Labs, Inc.... ByInvesting ...